Position in KYMR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$31,293,443
+$7,380,884 QoQ
Shares Held
272,900
-4.9% QoQ
Ownership
0.328%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#45
of 275 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. KYMR ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
This page
|
272,900 | $31,293,443 |
All Filings in KYMR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,293,443 | 272,900 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $23,912,559 | 287,100 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $17,209,860 | 221,178 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $11,843,436 | 209,248 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $10,254,090 | 234,970 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $5,531,258 | 202,092 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $9,194,968 | 228,560 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $9,792,293 | 206,894 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $6,531,299 | 218,804 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $8,795,920 | 218,804 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,747,831 | 186,482 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,558,739 | 184,082 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,297,045 | 99,915 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,785,664 | 94,015 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,984,694 | 79,515 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,711,448 | 78,615 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,509,750 | 76,676 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,532,111 | 83,462 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,607,436 | 88,320 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,992,264 | 67,965 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,136,252 | 64,665 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,033,637 | 26,599 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,426,062 | 23,001 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $717,314 | 22,201 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||